Clinical Trial Update: Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination therapy including the oncolytic virus H101 with SBRT, chemotherapy, targeted therapy, and immunotherapy for unre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases

Drugs mentioned

• Oncorine (H101 oncolytic adenovirus)

Snippet

Sponsor: Jun Huang | Conditions: CRC, Liver Metastasis Colon Cancer | Phase 2 | Status: NOT_YET_RECRUITING